EGCG, epigallocatechin-3-O-gallate

  • 文章类型: Journal Article
    慢性胰岛素抵抗抑制肌肉和肝脏对胰岛素的反应,部分原因是受损的囊泡贩运。我们在这里报道了一个由白藜芦醇组成的配方,阿魏酸和表没食子儿茶素-3-O-没食子酸酯在改善肌肉和肝脏胰岛素抵抗方面比抗糖尿病药物更有效,二甲双胍和AICAR。该配方通过调节胰岛素非依赖性(钙和AMPK)和胰岛素依赖性(PI3K)信号分子来增强胰岛素抵抗肌细胞中葡萄糖转运蛋白4(GLUT4)易位至质膜。特别是,它通过内体调节GLUT4的亚细胞位置,以增加胰岛素抵抗条件下的葡萄糖摄取。同时,这种植物化学物质组合增加了胰岛素抵抗肝细胞中糖原的合成并减少了葡萄糖的产生。另一方面,该配方还显示出抗糖尿病的潜力,通过减少肌管中的脂质含量,肝细胞,和脂肪细胞。这项研究表明,配方中的三种酚类化合物可以以不同的机制起作用,并增强胰岛素依赖性和独立的囊泡运输和葡萄糖转运机制,以改善碳水化合物和脂质代谢。
    Chronic insulin resistance suppresses muscle and liver response to insulin, which is partially due to impaired vesicle trafficking. We report here that a formula consisting of resveratrol, ferulic acid and epigallocatechin-3-O-gallate is more effective in ameliorating muscle and hepatic insulin resistance than the anti-diabetic drugs, metformin and AICAR. The formula enhanced glucose transporter-4 (GLUT4) translocation to the plasma membrane in the insulin-resistant muscle cells by regulating both insulin-independent (calcium and AMPK) and insulin-dependent (PI3K) signaling molecules. Particularly, it regulated the subcellular location of GLUT4 through endosomes to increase glucose uptake under insulin-resistant condition. Meanwhile, this phytochemicals combination increased glycogen synthesis and decreased glucose production in the insulin-resistant liver cells. On the other hand, this formula also showed anti-diabetic potential by the reduction of lipid content in the myotubes, hepatocytes, and adipocytes. This study demonstrated that the three phenolic compounds in the formula could work in distinct mechanisms and enhance both insulin-dependent and independent vesicles trafficking and glucose transport mechanisms to improve carbohydrate and lipid metabolism.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    最近,Nrf2/HO-1作为细胞内防御氧化应激的主要调控途径受到广泛关注,被认为是减轻内皮细胞损伤的理想靶点。
    本文旨在总结在ECs中潜在发挥抗氧化应激保护作用的天然单体/提取物。
    对我们的主题进行了文献检索,关键词为“动脉粥样硬化”或“Nrf2/HO-1”或“血管内皮细胞”或“氧化应激”或“草药”或“天然产物”或“天然提取物”或“天然化合物”或“中药”,基于草药经典书籍和科学数据库,包括Pubmed,SciFinder,Scopus,WebofScience,GoogleScholar,BaiduScholar,和其他人。然后,我们分析了不同类型的天然化合物通过保护血管内皮细胞免受氧化应激来治疗动脉粥样硬化的可能分子机制。此外,讨论了未来可能的研究前景。
    这些在ECs中对氧化应激具有保护作用的药物主要包括苯丙素类化合物,黄酮类化合物,萜类化合物,和生物碱。这些药物中的大多数缓解了由于氧化应激导致的ECs细胞凋亡,并且该机制与Nrf2/HO-1信令激活有关。然而,尽管通过激活Nrf2/HO-1信号发挥针对EC损伤的保护作用的天然药物的各个方面的研究不断取得进展,基于这些药物开发治疗动脉粥样硬化(AS)和其他心血管疾病的新药需要更详细的临床前和临床研究.
    我们的本文提供了通过激活Nrf2/HO-1对ECs抵抗氧化应激具有保护活性的天然试剂的最新信息。我们希望这篇综述将为进一步开发用于治疗AS和其他CVD的天然药物的新型候选药物提供一些方向。
    Recently, Nrf2/HO-1 has received extensive attention as the main regulatory pathway of intracellular defense against oxidative stress and is considered an ideal target for alleviating endothelial cell (EC) injury.
    This paper aimed to summarized the natural monomers/extracts that potentially exert protective effects against oxidative stress in ECs.
    A literature search was carried out regarding our topic with the keywords of \"atherosclerosis\" or \"Nrf2/HO-1\" or \"vascular endothelial cells\" or \"oxidative stress\" or \"Herbal medicine\" or \"natural products\" or \"natural extracts\" or \"natural compounds\" or \"traditional Chinese medicines\" based on classic books of herbal medicine and scientific databases including Pubmed, SciFinder, Scopus, the Web of Science, GoogleScholar, BaiduScholar, and others. Then, we analyzed the possible molecular mechanisms for different types of natural compounds in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. In addition, perspectives for possible future studies are discussed.
    These agents with protective effects against oxidative stress in ECs mainly include phenylpropanoids, flavonoids, terpenoids, and alkaloids. Most of these agents alleviate cell apoptosis in ECs due to oxidative stress, and the mechanisms are related to Nrf2/HO-1 signaling activation. However, despite continued progress in research on various aspects of natural agents exerting protective effects against EC injury by activating Nrf2/HO-1 signaling, the development of new drugs for the treatment of atherosclerosis (AS) and other CVDs based on these agents will require more detailed preclinical and clinical studies.
    Our present paper provides updated information of natural agents with protective activities on ECs against oxidative stress by activating Nrf2/HO-1. We hope this review will provide some directions for the further development of novel candidate drugs from natural agents for the treatment of AS and other CVDs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号